
Toni R. Scheiner
Examiner (ID: 14855)
| Most Active Art Unit | 1802 |
| Art Unit(s) | 1806, 1642, 1641, 1621, 1802 |
| Total Applications | 566 |
| Issued Applications | 411 |
| Pending Applications | 40 |
| Abandoned Applications | 115 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3775114
[patent_doc_number] => 05808000
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Virus-safe monomeric human immunoglobulin A and methods for its production'
[patent_app_type] => 1
[patent_app_number] => 8/500161
[patent_app_country] => US
[patent_app_date] => 1995-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 8561
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808000.pdf
[firstpage_image] =>[orig_patent_app_number] => 500161
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/500161 | Virus-safe monomeric human immunoglobulin A and methods for its production | Jul 9, 1995 | Issued |
Array
(
[id] => 3825789
[patent_doc_number] => 05759864
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Methods for reducing background binding in antibody preparations'
[patent_app_type] => 1
[patent_app_number] => 8/494136
[patent_app_country] => US
[patent_app_date] => 1995-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6365
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/759/05759864.pdf
[firstpage_image] =>[orig_patent_app_number] => 494136
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/494136 | Methods for reducing background binding in antibody preparations | Jun 22, 1995 | Issued |
Array
(
[id] => 4106108
[patent_doc_number] => 06057115
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-02
[patent_title] => 'Process for producing GM2 specific antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/491310
[patent_app_country] => US
[patent_app_date] => 1995-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 3605
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/057/06057115.pdf
[firstpage_image] =>[orig_patent_app_number] => 491310
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/491310 | Process for producing GM2 specific antibodies | Jun 15, 1995 | Issued |
Array
(
[id] => 3772795
[patent_doc_number] => 05849878
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Design and synthesis of bispecific reagents: use of double stranded DNAs as chemically and spatially defined cross-linkers'
[patent_app_type] => 1
[patent_app_number] => 8/481065
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 39
[patent_no_of_words] => 22266
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849878.pdf
[firstpage_image] =>[orig_patent_app_number] => 481065
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481065 | Design and synthesis of bispecific reagents: use of double stranded DNAs as chemically and spatially defined cross-linkers | Jun 6, 1995 | Issued |
Array
(
[id] => 3784430
[patent_doc_number] => 05736340
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Secreted Mac-2-binding glycoprotein'
[patent_app_type] => 1
[patent_app_number] => 8/473791
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 16066
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736340.pdf
[firstpage_image] =>[orig_patent_app_number] => 473791
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473791 | Secreted Mac-2-binding glycoprotein | Jun 6, 1995 | Issued |
Array
(
[id] => 4066433
[patent_doc_number] => 05866690
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Detection of malignant tumor cells'
[patent_app_type] => 1
[patent_app_number] => 8/487345
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 24334
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866690.pdf
[firstpage_image] =>[orig_patent_app_number] => 487345
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487345 | Detection of malignant tumor cells | Jun 6, 1995 | Issued |
Array
(
[id] => 3998385
[patent_doc_number] => 05858688
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Gro genes, proteins, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/474362
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 14209
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858688.pdf
[firstpage_image] =>[orig_patent_app_number] => 474362
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/474362 | Gro genes, proteins, and uses thereof | Jun 6, 1995 | Issued |
Array
(
[id] => 3806693
[patent_doc_number] => 05811248
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-22
[patent_title] => 'Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/480434
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 68
[patent_no_of_words] => 38177
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/811/05811248.pdf
[firstpage_image] =>[orig_patent_app_number] => 480434
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480434 | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof | Jun 6, 1995 | Issued |
Array
(
[id] => 3767129
[patent_doc_number] => 05849509
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Nuclear matrix proteins'
[patent_app_type] => 1
[patent_app_number] => 8/488036
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 14059
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849509.pdf
[firstpage_image] =>[orig_patent_app_number] => 488036
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488036 | Nuclear matrix proteins | Jun 6, 1995 | Issued |
| 08/478190 | MONOCLONAL ANTIBODY FRAGMENT TO HUMAN OVARIAN CANCERS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3831141
[patent_doc_number] => 05814469
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Method for diagnosing endometrial cancer'
[patent_app_type] => 1
[patent_app_number] => 8/484598
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10272
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814469.pdf
[firstpage_image] =>[orig_patent_app_number] => 484598
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484598 | Method for diagnosing endometrial cancer | Jun 6, 1995 | Issued |
Array
(
[id] => 3733710
[patent_doc_number] => 05698410
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-16
[patent_title] => 'Highly sensitive immunocytochemical method for diagnosis of malignant effusions'
[patent_app_type] => 1
[patent_app_number] => 8/473434
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3860
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/698/05698410.pdf
[firstpage_image] =>[orig_patent_app_number] => 473434
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473434 | Highly sensitive immunocytochemical method for diagnosis of malignant effusions | Jun 6, 1995 | Issued |
Array
(
[id] => 3701605
[patent_doc_number] => 05653978
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-05
[patent_title] => 'Human anti-Rh(D) monoclonal antibodies and methods of use of antibodies in immunotherapy'
[patent_app_type] => 1
[patent_app_number] => 8/470141
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5445
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/653/05653978.pdf
[firstpage_image] =>[orig_patent_app_number] => 470141
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470141 | Human anti-Rh(D) monoclonal antibodies and methods of use of antibodies in immunotherapy | Jun 5, 1995 | Issued |
Array
(
[id] => 3775219
[patent_doc_number] => 05808005
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Human carcinoma antigen'
[patent_app_type] => 1
[patent_app_number] => 8/484061
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 9440
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808005.pdf
[firstpage_image] =>[orig_patent_app_number] => 484061
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484061 | Human carcinoma antigen | Jun 5, 1995 | Issued |
Array
(
[id] => 3623987
[patent_doc_number] => 05620856
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Monoclonal antibody assay and kit for detecting metal cations in body fluids'
[patent_app_type] => 1
[patent_app_number] => 8/469489
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18382
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/620/05620856.pdf
[firstpage_image] =>[orig_patent_app_number] => 469489
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469489 | Monoclonal antibody assay and kit for detecting metal cations in body fluids | Jun 5, 1995 | Issued |
Array
(
[id] => 3733104
[patent_doc_number] => 05693763
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-02
[patent_title] => 'Antibodies to human carcinoma antigen'
[patent_app_type] => 1
[patent_app_number] => 8/468276
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 9426
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/693/05693763.pdf
[firstpage_image] =>[orig_patent_app_number] => 468276
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468276 | Antibodies to human carcinoma antigen | Jun 5, 1995 | Issued |
Array
(
[id] => 3766574
[patent_doc_number] => 05773230
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy'
[patent_app_type] => 1
[patent_app_number] => 8/469081
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 10096
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773230.pdf
[firstpage_image] =>[orig_patent_app_number] => 469081
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469081 | Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy | Jun 4, 1995 | Issued |
Array
(
[id] => 3714221
[patent_doc_number] => 05616469
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-01
[patent_title] => 'Method for estimating the biological potential of a selected carcinoma in a patient'
[patent_app_type] => 1
[patent_app_number] => 8/462791
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 6388
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/616/05616469.pdf
[firstpage_image] =>[orig_patent_app_number] => 462791
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462791 | Method for estimating the biological potential of a selected carcinoma in a patient | Jun 4, 1995 | Issued |
Array
(
[id] => 3525065
[patent_doc_number] => 05541076
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Methods for determining the invasiveness of a bladder tumor'
[patent_app_type] => 1
[patent_app_number] => 8/460496
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 25
[patent_no_of_words] => 13480
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/541/05541076.pdf
[firstpage_image] =>[orig_patent_app_number] => 460496
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460496 | Methods for determining the invasiveness of a bladder tumor | Jun 1, 1995 | Issued |
Array
(
[id] => 3528549
[patent_doc_number] => 05541298
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Method of determining metastatic potential of tumor cells'
[patent_app_type] => 1
[patent_app_number] => 8/459201
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 7801
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/541/05541298.pdf
[firstpage_image] =>[orig_patent_app_number] => 459201
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459201 | Method of determining metastatic potential of tumor cells | Jun 1, 1995 | Issued |